MRC1 and neoplasm: The comparisons of OS in homogenous mutation groups, even if hampered by few individuals in some subgroups, indicate that the relevance of primary tumour location is in large due to differences in clinical characteristics, metastatic sites, mutational- and MMR-status, and consequently, treatment allocation.